IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021 Read more about Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021 Ardelyx Provides Corporate Update Following Type A Meeting with FDA Read more about Ardelyx Provides Corporate Update Following Type A Meeting with FDA Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial Read more about Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial Ardelyx Reports Second Quarter 2021 Financial Results Read more about Ardelyx Reports Second Quarter 2021 Financial Results Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Read more about Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Read more about Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Muna Bhanji Member of the Compensation Committee Muna Bhanji Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021 Read more about Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021 Ardelyx to Present at the Jefferies 2021 Virtual Healthcare Conference Read more about Ardelyx to Present at the Jefferies 2021 Virtual Healthcare Conference Ardelyx Reports First Quarter 2021 Financial Results and Recent Business Highlights Read more about Ardelyx Reports First Quarter 2021 Financial Results and Recent Business Highlights Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021 Read more about Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021
Ardelyx Provides Corporate Update Following Type A Meeting with FDA Read more about Ardelyx Provides Corporate Update Following Type A Meeting with FDA
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial Read more about Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial
Ardelyx Reports Second Quarter 2021 Financial Results Read more about Ardelyx Reports Second Quarter 2021 Financial Results
Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Read more about Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Read more about Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021 Read more about Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021
Ardelyx to Present at the Jefferies 2021 Virtual Healthcare Conference Read more about Ardelyx to Present at the Jefferies 2021 Virtual Healthcare Conference
Ardelyx Reports First Quarter 2021 Financial Results and Recent Business Highlights Read more about Ardelyx Reports First Quarter 2021 Financial Results and Recent Business Highlights